ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026
[
Yanjie Zhou, He Zhang, Yalan Zhu, Pengjun Jiang, Tianyu Feng, Zhen Wu, Jie Chen
Abstract readEnglish Abstract
In one paragraphArticle in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Yanjie Zhou， （ 610041）Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University & Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China.ORCID 0009-0006-3322-3501 He Zhang， （ 610041）Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University & Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China.
Yalan Zhu， （ 610041）Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University & Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China.
Pengjun Jiang， （ 610041）Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University & Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China.
Tianyu Feng， （ 610041）Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University & Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China.
Zhen Wu， （ 610041）Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University & Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China.
Jie Chen， （ 610041）Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University & Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China.ORCID 0000-0002-5663-7444 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Objective: To investigate the expression pattern, prognostic significance, and underlying molecular mechanisms of mutY homolog ( Methods: The differential expression of Results: Conclusion:
Indexed as
Carcinoma, HepatocellularCell Cycle ProteinsDNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesDrug Resistance, NeoplasmLiver NeoplasmsBiomarkers, TumorDisease ProgressionGene Expression Regulation, NeoplasticHumansPrognosisSorafenibAPEX1 protein, humanBiomarkers, TumorCell Cycle ProteinsDNA-(Apurinic or Apyrimidinic Site) LyaseDNA GlycosylasesmutY adenine glycosylaseSorafenibAPEX1BiomarkerCell cycle regulationHepatocellular carcinomaMUTYH
Identifiers
PMID42021884
PMCPMC13095766
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390